Attached files

file filename
10-Q - FORM 10-Q - Savara Incc16551e10vq.htm
EX-10.7 - EXHIBIT 10.7 - Savara Incc16551exv10w7.htm
EX-31.2 - EXHIBIT 31.2 - Savara Incc16551exv31w2.htm
EX-31.1 - EXHIBIT 31.1 - Savara Incc16551exv31w1.htm
EX-10.6 - EXHIBIT 10.6 - Savara Incc16551exv10w6.htm
EX-10.9 - EXHIBIT 10.9 - Savara Incc16551exv10w9.htm
EX-10.10 - EXHIBIT 10.10 - Savara Incc16551exv10w10.htm
         
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of ADVENTRX Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian M. Culley, principal executive officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
  (i)  
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
  (ii)  
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
May 9, 2011
         
     
  /s/ Brian M. Culley    
  Brian M. Culley   
  Chief Executive Officer
(Principal Executive Officer) 
 
 
In connection with the Quarterly Report of ADVENTRX Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Patrick L. Keran, principal financial officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
  (i)  
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
  (ii)  
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
May 9, 2011
         
     
  /s/ Patrick L. Keran    
  Patrick L. Keran   
  President and Chief Operating Officer
(Principal Financial Officer)